As of January 2025, Huapont Life Sciences has a market cap of $1.25B. This makes Huapont Life Sciences the world's 6788th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.22B | -3.43% |
2023 | $1.26B | -8.63% |
2022 | $1.38B | -29.56% |
2021 | $1.96B | 30.69% |
2020 | $1.50B | 12.15% |
2019 | $1.34B | 7.16% |
2018 | $1.25B | -31.50% |
2017 | $1.83B | -25.80% |
2016 | $2.46B | -35.90% |
2015 | $3.84B | 103.54% |
2014 | $1.89B | 14.57% |
2013 | $1.65B | -5.54% |
2012 | $1.74B | 41.71% |
2011 | $1.23B | -35.53% |
2010 | $1.91B | 19.11% |
2009 | $1.60B | 237.24% |
2008 | $475.08M | -66.42% |
2007 | $1.41B | 313.76% |
2006 | $341.93M | 38.77% |
2005 | $246.40M | 2.34% |
2004 | $240.77M | - |